executive appointment
Myriad Genetics Q2 Revenues Decrease 10 Percent; CEO Mark Capone Steps Down
The company attributed its revenue shortfall to billing issues in the prenatal testing business and announced that CFO Bryan Riggsbee will be interim CEO.
Intel Exec Brings Tech, Personal Experience to Precision Medicine Initiative Job, Say Colleagues
Premium
"I'm on this planet thanks to being an early prototype of precision medicine myself," said Eric Dishman, who the NIH has picked to lead the PMI Cohort Program.
Trovagene Terminates CEO Schuh and CFO Zaniboni for Breach of Duty
The firm said the two executives failed to present a lucrative corporate opportunity to Trovagene and took it for their own personal benefit instead.
Flatley Named Executive Chairman of Illumina as deSouza Steps Up to CEO Role
The new appointments, which have been unanimously approved by the company's board, will become effective on July 5.
NantHealth Adds $250M to Financing Round
NEW YORK (GenomeWeb) – NantHealth announced on Wednesday that it has received a $250 million investment from the Kuwait Investment Authority and has named new members to its management team.
Sep 17, 2013
Personalis Establishes UK Subsidiary
Jan 23, 2013
Former Gen-Probe CEO Carl Hull Leaving Hologic
Nov 28, 2012
Genetic Technologies Names New Chairman, Acting CEO
Oct 11, 2012
Quest Diagnostics Launches Reorganization, Layoffs
Mar 21, 2012
Cartagenia Opens US Office
Mar 12, 2012
Helicos' Cash Decreases to $200K; CEO Goes Part-Time
Feb 15, 2012